Alzheimer's Disease Trial, Recruiting (NCT06733714)

Alzheimer's Disease Trial, Recruiting NCT06733714 Sponsor: Universidade Federal do Rio de Janeiro Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06733714 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are over 50 years old and generally in good health
You have noticed some concerns or complaints about your memory or thinking abilities

Who may not be able to join:

Your estimated general intelligence level is below a certain threshold (confirm with trial site)
You have a diagnosed dependence on substances such as alcohol or drugs, based on standard medical guidelines
You have a serious mental health condition or a serious brain/nervous system disorder
You have vision or hearing problems that have not been corrected (for example, with glasses or hearing aids)
You have fainted for an unexplained reason, or had a seizure, within the last year
You have previously had a stroke
You currently take blood-thinning medications (anticoagulants)
You have a metal implant inside your skull or a heart pacemaker
You have any other medical reason that would prevent you from safely receiving a specific type of gentle brain stimulation called tACS (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rogerio Panizzutti, Professor, UFRJ

Phone: +55:21-3938-5588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06733714

Sponsor: Universidade Federal do Rio de Janeiro

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +55:21-3938-5588

More information: https://clinicaltrials.gov/study/NCT06733714

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are over 50 years old and generally in good health
You have noticed some concerns or complaints about your memory or thinking abilities

Who may not be able to join:

Your estimated general intelligence level is below a certain threshold (confirm with trial site)
You have a diagnosed dependence on substances such as alcohol or drugs, based on standard medical guidelines
You have a serious mental health condition or a serious brain/nervous system disorder
You have vision or hearing problems that have not been corrected (for example, with glasses or hearing aids)
You have fainted for an unexplained reason, or had a seizure, within the last year
You have previously had a stroke
You currently take blood-thinning medications (anticoagulants)
You have a metal implant inside your skull or a heart pacemaker
You have any other medical reason that would prevent you from safely receiving a specific type of gentle brain stimulation called tACS (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universidade Federal do Rio de Janeiro

Registry

ClinicalTrials.gov

Start date

2 December 2024

Est. completion

1 March 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

MONTREAL COGNITIVE ASSESSMENT (MOCA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov